US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 167 actively recruiting studies with Wisconsin sites out of 167 registered in total. The busiest research areas in Wisconsin are Breast Cancer, Prostate Cancer, Colorectal Cancer. Leading sponsors running trials in the state include University of Wisconsin, Madison, Medical College of Wisconsin, National Cancer Institute (NCI). By stage, Wisconsin trials break down as Phase 1 (34), Phase 2 (47), Phase 3 (43), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
167
Recruiting Now
167
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (5)Prostate Cancer (4)Colorectal Cancer (3)Solid Tumor (3)Acute Myeloid Leukemia (3)Anxiety (3)Heart Failure (3)Mantle Cell Lymphoma (MCL) (3)Healthy (2)Metastatic Castration-resistant Prostate Cancer (2)Pancreatic Ductal Adenocarcinoma (2)Relapsing Remitting Multiple Sclerosis (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 167 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 167. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT06457503 Phase 4
Recruiting
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Particip...
Condition
Nasopharyngeal Cancer Recurrent
Enrollment
100 pts
Location
United States, Canada
Sponsor
Coherus Oncology, Inc.
View Trial →
NCT07479979 Phase 1, Phase 2
Recruiting
Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients W...
Condition
Relapse Multiple Myeloma
Enrollment
62 pts
Location
United States
Sponsor
Natalie Callander
View Trial →
NCT07169279 Phase 2
Recruiting
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplas...
Condition
Achondroplasia
Enrollment
77 pts
Location
United States, Australia, Canada
Sponsor
QED Therapeutics, a BridgeBio
View Trial →
NCT07037459 Phase 3
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejecti...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
5,056 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT05338697 N/A
Recruiting
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future...
Condition
Stroke
Enrollment
657 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT04383262 Phase 2
Recruiting
Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Red...
Condition
Laryngopharyngeal Reflux
Enrollment
104 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT06625073 Phase 4
Recruiting
Randomized Trial of SGLT2i in Heart Transplant Recipients
Condition
Heart Transplant
Enrollment
200 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
View Trial →
NCT06681688 Phase 1, Phase 2
Recruiting
Study of Complication Rates in Cataract Surgery Patients Treated With Combined P...
Condition
Cataract
Enrollment
94 pts
Location
United States
Sponsor
Inder Paul Singh, M.D.
View Trial →
NCT06665594 Phase 2
Recruiting
Effect of TXA on Reducing Bruising After Filler Injection
Condition
Facial Filler Injections
Enrollment
40 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06860594 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Th...
Condition
Astrocytoma, IDH-Mutant, Grade 2
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06408259 Phase 3
Recruiting
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimo...
Condition
Multiple Sclerosis, Relapsing-Remitting
Enrollment
194 pts
Location
United States, Australia, Italy
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07298460 Phase 1, Phase 2
Recruiting
Stimulation-based Therapy to Improve Balance in DCM
Condition
Degenerative Cervical Myelopathy
Enrollment
45 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT07218666 Phase 2
Recruiting
Zanzalintinib in Men With Aggressive Variant Prostate Cancer
Condition
Aggressive Variant Prostate Carcinoma
Enrollment
30 pts
Location
United States
Sponsor
Deepak Kilari
View Trial →
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT04075305 N/A
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using t...
Condition
Oncology
Enrollment
8,000 pts
Location
United States, Australia, Belgium
Sponsor
UMC Utrecht
View Trial →
NCT07224373 Phase 1
Recruiting
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
24 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT06883305 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participa...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
990 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
View Trial →
NCT07225972 Phase 3
Recruiting
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched...
Condition
CMV
Enrollment
138 pts
Location
United States
Sponsor
New York Medical College
View Trial →
NCT06474299 Phase 4
Recruiting
The Avenues Study: Dual Use Cessation
Condition
Smoking Cessation
Enrollment
500 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
Page 4 of 7 — 167 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology